ReviewCurrent oncology reports2026

Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies.

Andrea M Allen-Tejerina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.